Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Li, Rui ^a   Gao, Kaiming ^a   Luo, Hui ^a   Wang, Xiefeng ^a   Shi, Yan ^a   Dong, Qingsheng ^a   Luan, Wenkang ^a   You, Yongping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma; miRNA; Prognostic stratification

Indexed keywords

COHORT STUDIES; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RISK; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84892453256     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-33-9     Document Type: Article

References (25)

1. Glioblastoma. Penas-Prado M, Armstrong TS, Gilbert MR, Handb Clin Neurol 2012 105 485 506 22230514
2. Glioblastoma and other malignant gliomas: a clinical review. Omuro A, DeAngelis LM, JAMA 2013 310 1842 1850 10.1001/jama.2013.280319 24193082
3. Genetics of glioblastoma: a window into its imaging and histopathologic variability. Belden CJ, Valdes PA, Ran C, Pastel DA, Harris BT, Fadul CE, Israel MA, Paulsen K, Roberts DW, Radiographics 2011 31 1717 1740 10.1148/rg.316115512 21997991
4. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Rao SA, Santosh V, Somasundaram K, Mod Pathol 2010 23 1404 1417 10.1038/modpathol.2010.135 20711171
5. Buspirone in benzodiazepine withdrawal. Ashton CH, Rawlins MD, Tyrer SP, Br J Psychiatry 1991 158 283 284 2012925
6. The somatic genomic landscape of glioblastoma. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al. Cell 2013 155 462 477 10.1016/j.cell.2013.09.034 24120142
7. Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Zhang W, Zhang J, Yan W, You G, Bao Z, Li S, Kang C, Jiang C, You Y, Zhang Y, et al. Cancer 2013 119 814 824 10.1002/cncr.27826 22990979
8. Mitochondrial diversity and phylogeographic structure of Chinese domestic goats. Chen SY, Su YH, Wu SF, Sha T, Zhang YP, Mol Phylogenet Evol 2005 37 804 814 10.1016/j.ympev.2005.06.014 16051502 (Pubitemid 41597791)
9. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
10. Analysis of gene expression data using BRB-ArrayTools. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y, Canc Informat 2007 3 11 17 (Pubitemid 47075796)
11. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, et al. N Engl J Med 2004 351 2159 2169 10.1056/NEJMoa041869 15548776 (Pubitemid 39507628)
12. Cox survival analysis of microarray gene expression data using correlation principal component regression. Zhao Q, Sun J, Stat Appl Genet Mol Biol 2007 6 Article16
13. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Ohgaki H, Kleihues P, J Neuropathol Exp Neurol 2005 64 479 489 15977639 (Pubitemid 40781150)
14. Genetic pathways to glioblastoma: a population-based study. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, et al. Cancer Res 2004 64 6892 6899 10.1158/0008-5472.CAN-04-1337 15466178 (Pubitemid 39330996)
15. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Cancer cell 2010 17 98 110 10.1016/j.ccr.2009.12. 020 20129251
16. Oncogene addiction in gliomas: implications for molecular targeted therapy. Yan W, Zhang W, Jiang T, J Exp Clin Cancer Res 2011 30 58 10.1186/1756-9966-30-58 21575270
17. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Yan W, Zhang W, You G, Zhang J, Han L, Bao Z, Wang Y, Liu Y, Jiang C, Kang C, et al. Neuro Oncol 2012 14 1432 1440 10.1093/neuonc/nos263 23090983
18. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA, Cancer Res 2009 69 2091 2099 19244127
19. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, et al. Cancer cell 2010 17 510 522 10.1016/j.ccr.2010.03.017 20399149
20. Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. Zhang W, Yan W, You G, Bao Z, Wang Y, Liu Y, You Y, Jiang T, Cancer Lett 2013 328 120 125 10.1016/j.canlet.2012.08.033 22960273
21. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. Cancer cell 2006 9 157 173 10.1016/j.ccr.2006.02. 019 16530701 (Pubitemid 43357943)
22. Moving toward molecular classification of diffuse gliomas in adults. Theeler BJ, Yung WK, Fuller GN, De Groot JF, Neurology 2012 79 1917 1926 10.1212/WNL.0b013e318271f7cb 23109653
23. Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification. Li B, Senbabaoglu Y, Peng W, Yang ML, Xu J, Li JZ, Clin Cancer Res 2012 18 5595 5605 10.1158/1078-0432.CCR-12-1427 22912392
24. IDH1 and IDH2 mutations in gliomas. Cohen AL, Holmen SL, Colman H, Curr Neurol Neurosci Rep 2013 13 345 23532369
25. Predictive and prognostic factors for gliomas. Ducray F, Idbaih A, Wang XW, Cheneau C, Labussiere M, Sanson M, Expert Rev Anticancer Ther 2011 11 781 789 10.1586/era.10.202 21554053